{"entity":{"type":"insider","cik":"0001706847","url":"/insider/0001706847","json_url":"/insider/0001706847.json","name":"Velleca Mark A.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":48,"n_filings":22,"first":"2017-12-20","last":"2023-08-10","span_basis":"filed_date"},"name_variants":[{"name":"Velleca Mark A.","source":"filing","n_filings":22,"first_seen":"2017-12-20","last_seen":"2023-08-10"}],"transactions":[{"id":8084336,"accession":"0001562180-23-006271","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-23-006271","line_url":"/filing/0001562180-23-006271","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":1.9995679933333332,"price_display":"2.00","price_state":"stated","total_value":119974.0796,"total_display":"119,974.08","total_whole":"119,974","shares_owned_after":116000.0,"shares_owned_after_display":"116,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-08","filed_date":"2023-08-10","scope":"insider","n_lines":2},{"id":6187446,"accession":"0001562180-22-007293","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-007293","line_url":"/filing/0001562180-22-007293#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":11.6993,"price_display":"11.70","price_state":"stated","total_value":175489.5,"total_display":"175,489.50","total_whole":"175,490","shares_owned_after":116000.0,"shares_owned_after_display":"116,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-18","filed_date":"2022-10-20","scope":"insider"},{"id":6730856,"accession":"0001562180-22-006791","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-006791","line_url":"/filing/0001562180-22-006791#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":13.5022,"price_display":"13.50","price_state":"stated","total_value":270044.0,"total_display":"270,044.00","total_whole":"270,044","shares_owned_after":116000.0,"shares_owned_after_display":"116,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-20","filed_date":"2022-09-22","scope":"insider"},{"id":6393704,"accession":"0001562180-22-006214","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-22-006214","line_url":"/filing/0001562180-22-006214#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":80000.0,"shares_display":"80,000","price_per_share":12.6363,"price_display":"12.64","price_state":"stated","total_value":1010904.0,"total_display":"1,010,904.00","total_whole":"1,010,904","shares_owned_after":116000.0,"shares_owned_after_display":"116,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-16","filed_date":"2022-08-18","scope":"insider"},{"id":4263132,"accession":"0001562180-21-004949","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-21-004949","line_url":"/filing/0001562180-21-004949#line-6","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":18.4898,"price_display":"18.49","price_state":"stated","total_value":184898.0,"total_display":"184,898.00","total_whole":"184,898","shares_owned_after":61000.0,"shares_owned_after_display":"61,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-15","filed_date":"2021-07-15","scope":"insider"},{"id":4263124,"accession":"0001562180-21-004949","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-004949","line_url":"/filing/0001562180-21-004949#line-4","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.0824,"price_display":"19.08","price_state":"stated","total_value":190824.0,"total_display":"190,824.00","total_whole":"190,824","shares_owned_after":61000.0,"shares_owned_after_display":"61,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-15","scope":"insider"},{"id":4263117,"accession":"0001562180-21-004949","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-004949","line_url":"/filing/0001562180-21-004949#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.4536,"price_display":"19.45","price_state":"stated","total_value":194536.0,"total_display":"194,536.00","total_whole":"194,536","shares_owned_after":61000.0,"shares_owned_after_display":"61,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-13","filed_date":"2021-07-15","scope":"insider"},{"id":4899887,"accession":"0001562180-21-004348","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-21-004348","line_url":"/filing/0001562180-21-004348#line-6","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.7728,"price_display":"21.77","price_state":"stated","total_value":217728.0,"total_display":"217,728.00","total_whole":"217,728","shares_owned_after":61000.0,"shares_owned_after_display":"61,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-17","scope":"insider"},{"id":4899878,"accession":"0001562180-21-004348","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-004348","line_url":"/filing/0001562180-21-004348#line-4","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.7384,"price_display":"21.74","price_state":"stated","total_value":217384.0,"total_display":"217,384.00","total_whole":"217,384","shares_owned_after":61000.0,"shares_owned_after_display":"61,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-16","filed_date":"2021-06-17","scope":"insider"},{"id":4899869,"accession":"0001562180-21-004348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-004348","line_url":"/filing/0001562180-21-004348#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.3909,"price_display":"22.39","price_state":"stated","total_value":223909.0,"total_display":"223,909.00","total_whole":"223,909","shares_owned_after":61000.0,"shares_owned_after_display":"61,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-17","scope":"insider"},{"id":5416125,"accession":"0001562180-21-003460","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-21-003460","line_url":"/filing/0001562180-21-003460#line-6","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.5413,"price_display":"20.54","price_state":"stated","total_value":205413.0,"total_display":"205,413.00","total_whole":"205,413","shares_owned_after":41000.0,"shares_owned_after_display":"41,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-13","filed_date":"2021-05-13","scope":"insider"},{"id":5416120,"accession":"0001562180-21-003460","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-003460","line_url":"/filing/0001562180-21-003460#line-4","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.0691,"price_display":"20.07","price_state":"stated","total_value":200691.0,"total_display":"200,691.00","total_whole":"200,691","shares_owned_after":41000.0,"shares_owned_after_display":"41,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-12","filed_date":"2021-05-13","scope":"insider"},{"id":5416114,"accession":"0001562180-21-003460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-003460","line_url":"/filing/0001562180-21-003460#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.0997,"price_display":"19.10","price_state":"stated","total_value":190997.0,"total_display":"190,997.00","total_whole":"190,997","shares_owned_after":41000.0,"shares_owned_after_display":"41,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-11","filed_date":"2021-05-13","scope":"insider"},{"id":5436094,"accession":"0001562180-21-002835","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-21-002835","line_url":"/filing/0001562180-21-002835#line-6","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":24.9631,"price_display":"24.96","price_state":"stated","total_value":249631.0,"total_display":"249,631.00","total_whole":"249,631","shares_owned_after":41000.0,"shares_owned_after_display":"41,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-15","scope":"insider"},{"id":5436089,"accession":"0001562180-21-002835","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-002835","line_url":"/filing/0001562180-21-002835#line-4","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":24.5272,"price_display":"24.53","price_state":"stated","total_value":245272.0,"total_display":"245,272.00","total_whole":"245,272","shares_owned_after":41000.0,"shares_owned_after_display":"41,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-14","filed_date":"2021-04-15","scope":"insider"},{"id":5436082,"accession":"0001562180-21-002835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-002835","line_url":"/filing/0001562180-21-002835#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":23.8865,"price_display":"23.89","price_state":"stated","total_value":238865.0,"total_display":"238,865.00","total_whole":"238,865","shares_owned_after":41000.0,"shares_owned_after_display":"41,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-15","scope":"insider"},{"id":4697455,"accession":"0001562180-21-001280","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001562180-21-001280","line_url":"/filing/0001562180-21-001280#line-9","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":26.0152,"price_display":"26.02","price_state":"stated","total_value":260152.0,"total_display":"260,152.00","total_whole":"260,152","shares_owned_after":41000.0,"shares_owned_after_display":"41,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-18","filed_date":"2021-02-18","scope":"insider"},{"id":4697447,"accession":"0001562180-21-001280","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001562180-21-001280","line_url":"/filing/0001562180-21-001280","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":27.643336,"price_display":"27.64","price_state":"stated","total_value":276433.36,"total_display":"276,433.36","total_whole":"276,433","shares_owned_after":41600.0,"shares_owned_after_display":"41,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-17","filed_date":"2021-02-18","scope":"insider","n_lines":2},{"id":4697438,"accession":"0001562180-21-001280","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-21-001280","line_url":"/filing/0001562180-21-001280","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11040.0,"shares_display":"11,040","price_per_share":35.204055733695654,"price_display":"35.20","price_state":"stated","total_value":388652.7753,"total_display":"388,652.78","total_whole":"388,653","shares_owned_after":43723.0,"shares_owned_after_display":"43,723","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-18","scope":"insider","n_lines":3},{"id":4790159,"accession":"0001562180-21-000442","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001562180-21-000442","line_url":"/filing/0001562180-21-000442#line-7","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.64,"price_display":"20.64","price_state":"stated","total_value":206400.0,"total_display":"206,400.00","total_whole":"206,400","shares_owned_after":41000.0,"shares_owned_after_display":"41,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-21","filed_date":"2021-01-21","scope":"insider"},{"id":4790151,"accession":"0001562180-21-000442","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001562180-21-000442","line_url":"/filing/0001562180-21-000442#line-5","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":21.5107,"price_display":"21.51","price_state":"stated","total_value":215107.0,"total_display":"215,107.00","total_whole":"215,107","shares_owned_after":37000.0,"shares_owned_after_display":"37,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-20","filed_date":"2021-01-21","scope":"insider"},{"id":4790137,"accession":"0001562180-21-000442","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-21-000442","line_url":"/filing/0001562180-21-000442#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":20.8781,"price_display":"20.88","price_state":"stated","total_value":208781.0,"total_display":"208,781.00","total_whole":"208,781","shares_owned_after":37000.0,"shares_owned_after_display":"37,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-19","filed_date":"2021-01-21","scope":"insider"},{"id":2239921,"accession":"0001562180-20-007341","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001562180-20-007341","line_url":"/filing/0001562180-20-007341#line-6","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.9668,"price_display":"19.97","price_state":"stated","total_value":199668.0,"total_display":"199,668.00","total_whole":"199,668","shares_owned_after":37000.0,"shares_owned_after_display":"37,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-17","scope":"insider"},{"id":2239915,"accession":"0001562180-20-007341","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-20-007341","line_url":"/filing/0001562180-20-007341#line-4","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.2021,"price_display":"19.20","price_state":"stated","total_value":192021.0,"total_display":"192,021.00","total_whole":"192,021","shares_owned_after":37000.0,"shares_owned_after_display":"37,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-17","scope":"insider"},{"id":2239909,"accession":"0001562180-20-007341","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-20-007341","line_url":"/filing/0001562180-20-007341#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":19.4297,"price_display":"19.43","price_state":"stated","total_value":194297.0,"total_display":"194,297.00","total_whole":"194,297","shares_owned_after":37000.0,"shares_owned_after_display":"37,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"},{"id":6160518,"accession":"0001562180-18-004596","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-18-004596","line_url":"/filing/0001562180-18-004596","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":39.8421503,"price_display":"39.84","price_state":"stated","total_value":199210.7515,"total_display":"199,210.75","total_whole":"199,211","shares_owned_after":19015.0,"shares_owned_after_display":"19,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-16","scope":"insider","n_lines":2},{"id":6755642,"accession":"0001562180-18-004218","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-18-004218","line_url":"/filing/0001562180-18-004218","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":41.52906854,"price_display":"41.53","price_state":"stated","total_value":207645.3427,"total_display":"207,645.34","total_whole":"207,645","shares_owned_after":19000.0,"shares_owned_after_display":"19,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-15","filed_date":"2018-10-15","scope":"insider","n_lines":2},{"id":5988512,"accession":"0001562180-18-003988","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-18-003988","line_url":"/filing/0001562180-18-003988","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":66.3098126,"price_display":"66.31","price_state":"stated","total_value":331549.063,"total_display":"331,549.06","total_whole":"331,549","shares_owned_after":11165.0,"shares_owned_after_display":"11,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-17","filed_date":"2018-09-19","scope":"insider","n_lines":3},{"id":6705159,"accession":"0001562180-18-003666","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-18-003666","line_url":"/filing/0001562180-18-003666","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":55.87560168,"price_display":"55.88","price_state":"stated","total_value":279378.0084,"total_display":"279,378.01","total_whole":"279,378","shares_owned_after":11301.0,"shares_owned_after_display":"11,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-15","filed_date":"2018-08-17","scope":"insider","n_lines":2},{"id":6424548,"accession":"0001562180-18-003317","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001562180-18-003317","line_url":"/filing/0001562180-18-003317","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":42.062624,"price_display":"42.06","price_state":"stated","total_value":210313.12,"total_display":"210,313.12","total_whole":"210,313","shares_owned_after":10200.0,"shares_owned_after_display":"10,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-16","filed_date":"2018-07-17","scope":"insider","n_lines":2},{"id":6102371,"accession":"0001562180-18-002515","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-18-002515","line_url":"/filing/0001562180-18-002515","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":46.27521466666666,"price_display":"46.28","price_state":"stated","total_value":347064.11,"total_display":"347,064.11","total_whole":"347,064","shares_owned_after":1700.0,"shares_owned_after_display":"1,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-15","filed_date":"2018-05-16","scope":"insider","n_lines":2},{"id":6029310,"accession":"0001562180-18-001897","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001562180-18-001897","line_url":"/filing/0001562180-18-001897","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":35.99618666666667,"price_display":"36.00","price_state":"stated","total_value":269971.4,"total_display":"269,971.40","total_whole":"269,971","shares_owned_after":500.0,"shares_owned_after_display":"500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-16","filed_date":"2018-04-17","scope":"insider","n_lines":2},{"id":6550361,"accession":"0001562180-18-001643","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-001643","line_url":"/filing/0001562180-18-001643#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":38.1955,"price_display":"38.20","price_state":"stated","total_value":286466.25,"total_display":"286,466.25","total_whole":"286,466","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-03-15","filed_date":"2018-03-16","scope":"insider"},{"id":6581121,"accession":"0001562180-18-001026","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-001026","line_url":"/filing/0001562180-18-001026#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":20.002,"price_display":"20.00","price_state":"stated","total_value":150015.0,"total_display":"150,015.00","total_whole":"150,015","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-16","scope":"insider"},{"id":6166365,"accession":"0001562180-18-000325","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-18-000325","line_url":"/filing/0001562180-18-000325#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":22.986,"price_display":"22.99","price_state":"stated","total_value":172395.0,"total_display":"172,395.00","total_whole":"172,395","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-16","filed_date":"2018-01-17","scope":"insider"},{"id":4724129,"accession":"0001562180-17-003961","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001562180-17-003961","line_url":"/filing/0001562180-17-003961#line-2","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001706847","owner_name":"Velleca Mark A.","owner_display_name":"Velleca Mark A.","owner_url":"/insider/0001706847","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":20.0141,"price_display":"20.01","price_state":"stated","total_value":150105.75,"total_display":"150,105.75","total_whole":"150,106","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-18","filed_date":"2017-12-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":48,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":48,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":48},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001560241","name":"G1 Therapeutics, Inc.","url":"/issuer/0001560241","role":"Director, Officer (President and CEO)","n_filings":22,"first_seen":"2017-12-20","last_seen":"2023-08-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001706847","retrieved_at":"2026-08-25T02:10:33+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}